Sentieon Seeks to Build Business Around Faster, More Accurate Genomic Analysis Software | GenomeWeb

NEW YORK (GenomeWeb) – Mountain View, Calif.-based Sentieon is hoping to earn a livelihood from improved or redesigned versions of widely used bioinformatics programs.

The company intends to "enable precision genomics data for precision medicine" by offering more efficient implementations of existing tools for secondary genomic data analysis so that they produce comparable or more accurate results in a fraction of the time, according to Sentieon CEO Jun Ye.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.